5 reports

The standardizations for automated quantitation are being enabled though the proprietary image analysis platform and digital pathology capabilities developed by Flagship Biosciences.

  • Neurological Disorder
  • Pathology
  • Therapy
  • Market Size
  • Santhera Pharmaceuticals Holding AG
  • IDEBENONE - DRUG PROFILE

It is a small molecule which acts by controlling the oxidative and redox pathologies responsible for defects in mitochondria.

  • Pathology
  • Research And Development
  • Therapy
  • United States
  • Santhera Pharmaceuticals Holding AG

pathologies, gout and other diseases.

  • Pathology
  • Europe
  • United States
  • Company
  • Santhera Pharmaceuticals Holding AG
  • Discovery/Preclinical Trial Details

Mechanism of Action R& D Progress Research and Development Brief Licensing and Collaboration Discovery/ Preclinical Trial Details As on June, 2011 Santhera Pharmaceuticals Holding AG announced that Intraocular injection of rotenone in mice results in retinal pathology comparable to t

  • Pathology
  • Europe
  • World
  • Product Initiative
  • Santhera Pharmaceuticals Holding AG

Intraocular injection of rotenone in mice results in retinal pathology comparable to the clinical presentation of LHON.

  • Pathology
  • R&D
  • Research And Development
  • Therapy
  • Santhera Pharmaceuticals Holding AG